Skip to content

Stop IGT progression to TPYE 2 DIABETES and reverse to NGT with SZ-A: a multicentre prospective, random, double-blind and simulation, parallel control 2 years study

Stop IGT progression to TPYE 2 DIABETES and reverse to NGT with SZ-A: a multicentre prospective, random, double-blind and simulation, parallel control 2 years study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060997
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre diabetes

Interventions

experimental group:Lifestyle+SZ-A
control group:Lifestyle +placebo

Sponsors

Beijing Anzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. It meets the diagnostic criteria of pre diabetes; 2. Aged >= 20 and = 20 and <= 35kg/m2; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Recent cardiovascular and cerebrovascular events; a) Cerebrovascular accident within 6 months: hemorrhagic stroke and ischemic stroke b) Severe organic heart disease: ST elevation myocardial infarction, St non elevation myocardial infarction and unstable angina pectoris; c) Other organic heart diseases: chronic heart failure, acute heart failure, atrioventricular block above grade II, sick sinus syndrome; d) Large aneurysm or dissecting aneurysm; 2. Patients with impaired liver and kidney function (AST and ALT are 1.5 times or above the upper limit of normal value, Cr exceeds the normal value: Patients with positive urinary protein and hematuria (non female menstrual period); 3. Fasting triglyceride >= 10mmol/L; 4. Hyperthyroidism and other endocrine diseases, autoimmune diseases, tumors or any serious fatal diseases; 5. Taking drugs that have a great impact on blood glucose (such as glucocorticoids); 6. Pregnant or pregnant women and lactating women; 7. Mental illness, lack of self-control or inability to accurately express intention; Or not in accordance with the author (those who cannot cooperate with dietary control, or do not use drugs according to regulations and affect the curative effect); 8. Within two weeks or currently participating in other clinical researchers; 9. Allergic constitution.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose;OGTT;HbAlc;

Secondary

MeasureTime frame
TC;TG;insulin;HDL-L;LDL-C;ALT;BUN;Cr;ECG;

Countries

China

Contacts

Public Contactmaliping

Beijing Anzhen Hospital

maliping65@126.com13901249835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026